rs146635122

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001365999.1(SZT2):​c.9723G>A​(p.Ala3241Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00147 in 1,593,688 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 14 hom. )

Consequence

SZT2
NM_001365999.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.170

Publications

1 publications found
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
SZT2-AS1 (HGNC:41225): (SZT2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-43448238-G-A is Benign according to our data. Variant chr1-43448238-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.17 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00147 (2115/1441452) while in subpopulation MID AF = 0.0119 (68/5722). AF 95% confidence interval is 0.00962. There are 14 homozygotes in GnomAdExome4. There are 1117 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SZT2NM_001365999.1 linkc.9723G>A p.Ala3241Ala synonymous_variant Exon 69 of 72 ENST00000634258.3 NP_001352928.1
SZT2NM_015284.4 linkc.9552G>A p.Ala3184Ala synonymous_variant Exon 68 of 71 NP_056099.3
SZT2-AS1NR_046744.1 linkn.407C>T non_coding_transcript_exon_variant Exon 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SZT2ENST00000634258.3 linkc.9723G>A p.Ala3241Ala synonymous_variant Exon 69 of 72 5 NM_001365999.1 ENSP00000489255.1

Frequencies

GnomAD3 genomes
AF:
0.00147
AC:
223
AN:
152118
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.0308
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00106
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00219
AC:
459
AN:
209772
AF XY:
0.00225
show subpopulations
Gnomad AFR exome
AF:
0.000339
Gnomad AMR exome
AF:
0.000617
Gnomad ASJ exome
AF:
0.0253
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.00340
GnomAD4 exome
AF:
0.00147
AC:
2115
AN:
1441452
Hom.:
14
Cov.:
32
AF XY:
0.00156
AC XY:
1117
AN XY:
715642
show subpopulations
African (AFR)
AF:
0.000458
AC:
15
AN:
32784
American (AMR)
AF:
0.000643
AC:
27
AN:
41970
Ashkenazi Jewish (ASJ)
AF:
0.0247
AC:
635
AN:
25708
East Asian (EAS)
AF:
0.0000261
AC:
1
AN:
38248
South Asian (SAS)
AF:
0.00301
AC:
252
AN:
83764
European-Finnish (FIN)
AF:
0.0000195
AC:
1
AN:
51348
Middle Eastern (MID)
AF:
0.0119
AC:
68
AN:
5722
European-Non Finnish (NFE)
AF:
0.000853
AC:
940
AN:
1102402
Other (OTH)
AF:
0.00296
AC:
176
AN:
59506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
138
275
413
550
688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00146
AC:
222
AN:
152236
Hom.:
2
Cov.:
32
AF XY:
0.00121
AC XY:
90
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41542
American (AMR)
AF:
0.00111
AC:
17
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0308
AC:
107
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00106
AC:
72
AN:
68008
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00283
Hom.:
0
Bravo
AF:
0.00143
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SZT2: BP4, BP7 -

Developmental and epileptic encephalopathy, 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 31, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
9.4
DANN
Benign
0.73
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146635122; hg19: chr1-43913909; API